As the nation sits embroiled over the battle of where to draw the line on ESCR (Embryonic stem cell research) the real issue that truly divides us is whether embryonic stems represent a who or a what. In other words, are we talking about people or property? Since Roe v. Wade we have not been willing or able as a nation to address the issue.
Stem cell research and human cloning are about transforming the mystery of majesty of life into a mere malleable and marketable commodity. In the short term, this is big business and offers great fame and fortune to the pioneers of biotech companies who master their secrets and harness the power of life through ESCR.
According to *Research and Markets, Nov. 2011 Global Market Watch Report, global market value for the biorepositories market is anticipated to be worth US$23.9 billion by 2015 and market CAGR (compound annual growth rate) of 7.9%.
On a global scale, North America accounts for more than 30% of the market. While US accounts for the highest share of the global market value on a country basis, India and China surpasses the US in terms of growth rate anticipated in the near future and leads the world.
** Stem Cell Biobank market trends as described in the Global Market Watch Report: Stem Cell Biobanking-A Rapid Growing Market, Stem Cell Treatments Give New Expectation, Anti-Aging Industry Goes For Stem Cell Therapy, Hottest Developments In Stem Cells Treatments, and Stem Cell Progress Being Hit By Traditionalists.
Naturally, after stumbling upon this report it was essential to know why a life issue had market trends passively described as if it were a standard commodity in the financial section. Upon my discovery is the fact that fetal stem cells are in use with the anti-aging therapy industry.
EmCell’s marketing strategy:
Moving Towards a New Era in Anti-Aging – In this age of abundance, people’s definition of anti-aging is no longer limited to health; it also includes the preservation of appearance, mental and physical abilities. Based on the general concept that people not only want to live longer, but also to live better, “anti-aging” has become a hot topic of discussion.
In anti-aging medicine, aging is defined as a process that is continuous, universal, progressive, intrinsic and deleterious; it will reduce life’s capability of adjusting to external environments. Interestingly, the five elements of this process can be acronymic into CUPID, the God of Love, whose eternal youth and beauty are such contrast to the transience of human life. However, with the breakthroughs and advancements in medical research, aging is no longer a process that is unstoppable. Fetal Stem Cell Transplantation (FSCT), a subject that has been actively discussed by global media in the recent years, is gradually gaining the recognition as an innovative anti-aging therapy. http://www.emcell.com/en/list_of_diseases/anti-aging-treatment/1514/1611.htm
Anti-Aging Treatment: EmCell clinic offers effective anti-aging treatment with fetal stem cells. Anti-aging therapy helps to improve overall physical condition of the patients resulting in less tiredness, improvement of gait and posture, and work capacity. Mental capacities improve, leading to acceleration of decision making and restoration of the short-term memory; and emotional balance is achieved. Anti-aging treatment with fetal stem cells leads to marked cosmetic effects, such as skin color improvement, fewer wrinkles, skin lifting and sparkling eyes. http://www.emcell.com/en/list_of_diseases/anti-aging-treatment.htm
HesCell Clinic As EmCell Clinic’s representative in Asia, HesCell Clinic is in charge of reviewing the medical cases of patients from the Asian region, and preparing medical reports based on individual’s condition which are sent to EmCell Clinic. http://www.emcell.com/en/list_of_diseases/anti-aging-treatment/1514/1611.htm http://www.med.umich.edu/medschool/hes/index.html
Pictures frequently say it more effectively … A Window to the Womb!

8-Weeks Conception

20-Weeks Conception

7-Weeks Conception

14-Weeks Conception
Could something that is clearly evil in its origin ever be justified based on what might appear to be for overall “good of society”? When we explore the hard facts, little doubt should be left in anyone’s mind as to what sort of damage we are truly inflicting.
When one performs an act that is intended to bring about a benefit for the greater good of society, if an innocent person is harmed, it is not a moral act. It is in fact, utilitarianism, a modern Hedonistic theory that promotes the greatest good for the greatest number of people..
Proponents of aborted fetal tissue research argue that their work is morally separate from the abortion itself and that one’s personal view should not affect the ethical considerations in the good that may result from such research. However, when we examine the impact fetal tissue research has on institutionalizing abortion, coupled with the direct complicity of all parties involved there is unquestionable proof that one cannot be separated from the other.
If one accepts that the unborn child is a human being, it follows then that this tiny person also has human rights, and therefore the practice of removing organs and tissues without consent and against their will violates every moral principle known to man. Further, if there were no ethical alternative, then the practice of such research would depend solely upon the continuing practice of abortion. And when we examine not only how many abortions were done in the past, what is projected for the future the numbers are both heart wrenching and staggering.
It is critical that we learn who is benefiting from abortion that leads to the anti-aging market.
As per below, Ambassador Ann Wagner is pictured with John McCain but her presence is NOT an implication of Ann Wagner’s involvement around this issue. This began with research into TGen, which led to John McCain, and then to Luxembourg. It appears Ann is simply pictured in support for guests visiting.
TGen is partnered with other biobank and biotechnology companies around the world. The established association with Institute for Systems Biology (ISB) Dr. Leroy Hood, and Amgen is important to note. Part II will provide further information around the funding and other partnerships associated.
I recall Senator McCain called the Tea Party “Hobbits” from the Senate floor! “…Tea Party Hobbits could return to middle earth having defeated Mordor.” Well not to go all geek on you, Senator, but they were already IN Middle Earth! They had to return to The Shire. -3 internets to you Senator! Best regards, Hobbits-stlsource! http://www.theblaze.com/stories/mccain-references-tea-party-hobbits-on-senate-floor/
Senator McCain was on a working visit to Luxembourg in March, to discuss the TGen biomedical research project launched in June 2008 with the Ministries of Economy, Research and Health.

Sixty-five years after American and Allied troops liberated Luxembourg from Nazi oppression in world War II, U.S. Senator from Arizona and former Republican Presidential candidate, John McCain, together with U.S. Ambassador Ann L.Wagner, remembered fallen American soldiers at the American Military Cemetery and Memorial in Hamm. After the cemetery visit, Senator McCain toured Luxembourg city. http://luxembourgbusiness.org/Spring-2009-Business-Journal.pdf
*** Senator John McCain is in favor of research to more embryonic stem cell line expanding embryonic stem cell research. (Jun 2004) He supports fetal tissue research. (Jan 2000) Senator McCain voted YES on expanding research to more embryonic stem cell lines. (Apr 2007)
Leading U.S. Bioscience Pioneers Enter International Collaboration to Accelerate Biomedical Research
The U.S. organizations involved in the collaboration are: The Partnership for Personalized Medicine (PPM) led by Dr. Leland H. Hartwell, director, Nobel Laureate in Physiology or Medicine in 2001 and president of the Fred Hutchinson Cancer Research Center in Seattle, Washington; The Institute for Systems Biology (ISB), also in Seattle, led by Dr. Leroy Hood, president of ISB and co-founder of U.S.-based Amgen Inc.; and Arizona’s Translational Genomics Research Institute (TGen), led by Dr. Jeffrey Trent, president and scientific director of TGen and former scientific director at the National Human Genome Research Institute of the National Institutes of Health. http://www.tgen.org/news/index.cfm?newsid=1167 Translational Genomics Research Institute (TGen) Institute for Systems Biology (ISB) Partnership for Personalized Medicine (PPM)
A pillar in the biotechnology field, Dr. Hood has played a role in founding more than fourteen biotechnology companies, including Amgen, Applied Biosystems, Darwin, The Accelerator and Integrated Diagnostics.
Whitman College Commencement Address by Dr. Leroy Hood: There are two types of stem cells: embryonic stem cells, and adult stem cells. There are those who believe, based on religious convictions, that it is okay to use adult stem cells but not embryonic stem cells. Unfortunately, adult stem cells have inevitably lost many of their options for development. Hence, it is only embryonic stem cells that hold the diverse potential required for the myriad of preventive therapies that will be necessary for medicine of the future. http://www.systemsbiology.org/download/whitman.pdf
Patent Number: 6136952 Human jagged polypeptide, encoding nucleic acids and methods of use this patent covers the composition of matter of JAGGED and various peptide derivatives. JAGGED is important embryonically for development, as well it has stimulatory activity on a wide variety of stem cells. Inventors: Li, Linheng (Seattle, WA); Hood, Leroy (Seattle, WA) Assignee: University of Washington (Seattle, WA) http://www.stemcellpatents.com/patents-show-631
Part II to follow soon …
_________________________________________________________________________
References & Definitions:
Fetal Stem Cells: primitive cell types, found in the organs of 6-week to 2-month old fetuses. When transplanted into an adult, their immature developmental stage frequently causes them to fail as replacements for the cells that are damaged.
Embryonic Stem Cells come from embryos that are 4 to 5 days old, at this stage, these cells can divide into more stem cells or they can specialize and develop into any type of body cell. Because of the versatility, these cells have the highest potential for regenerating or repairing tissue and organs in the human beings.
Human Embryonic and Adult Stem Cells each have advantages and disadvantages regarding potential use for cell-based regenerative procedures. One major difference between adult and embryonic stem cells is their different abilities in the number and type of differentiated cell types they can become. Embryonic stem cells can become all cell types of the body because they are pluripotent. Adult stem cells are thought to be limited to differentiating into different cell types for their tissue of origin.
* http://www.researchandmarkets.com/reports/1956015/biobanking_ownership_a_global_market_watch_2009
**(pg.10) http://pdf.marketpublishers.com/axisresearchmind/biobanking_technologies_a_global_market_watch_2009_2015.pdf
*** http://webcache.googleusercontent.com/search?q=cache:vQSpKKkT5A4J:www.issues2000.org/John_McCain.htm+abortions+to+stem+cell+research&cd=11&hl=en&ct=clnk&gl=us
http://www.pwc.lu/en/life-sciences
http://www.lifenews.com/
http://www.nrlc.org/
http://luxembourgbusiness.org/Spring-2009-Business-Journal.pdf http://www.ibbl.lu/about-the-ibbl/overview/
http://stemcells.nih.gov/info/basics/basics3.asp
“we write what we learn about”